Bedrijfsoverzicht
The Cigna Group operates as a comprehensive provider of insurance and related products and services primarily within the United States market. The organization functions through two distinct segments, Evernorth Health Services and Cigna Healthcare, which collectively deliver pharmacy benefit services alongside specialty and other healthcare solutions. As a major entity within the Healthcare sector, specifically the Healthcare Plans industry, the company leverages its extensive infrastructure to manage risk and provide coverage for diverse populations. The firm commands a substantial market capitalization of $72.46B, supported by an annual revenue stream of $274.90B and a workforce comprising 65,669 employees. These valuation and revenue figures indicate that the entity holds a significant position in the healthcare insurance landscape, reflecting its established scale and operational footprint relative to smaller competitors in the sector.
Financiële gezondheid
The company reported a trailing twelve-month revenue of $274.90B, generating a net income of $5.96B and an EBITDA of $12.05B during the same period. The substantial gap between the $274.90B in revenue and the $5.96B in net income reveals a cost structure characterized by high operating expenses, resulting in a net profit margin of only 2.2%. Free cash flow for the period stood at $9.77B, which provides the organization with significant financial flexibility to fund operations, service debt, or pursue strategic initiatives without relying heavily on external financing. The gross margin sits at 9.3%, the operating margin at 3.5%, and the profit margin at 2.2%, indicating that the business model relies on volume and efficiency rather than high per-unit profitability. On the balance sheet, the company holds $8.73B in cash against $31.46B in debt, resulting in a debt-to-equity ratio of 75.14, which suggests a leveraged capital structure typical for capital-intensive insurance operations. The current ratio is 0.85, indicating that the company's current assets are slightly below its current liabilities, which implies a need for careful management of short-term liquidity to meet obligations. Return on Equity is 15.1% and Return on Assets is 4.1%, metrics that reveal management's effectiveness in generating returns from shareholders' equity and the total asset base, respectively.
Waarderingsbeoordeling
The trailing twelve-month P/E ratio is 12.22, while the forward P/E is 8.11, implying that the market expects earnings to increase significantly in the future to justify the lower forward multiple. The price-to-book ratio stands at 1.71, indicating that the stock trades at a 71% premium over its book value, reflecting investor confidence in the company's intangible assets and future earnings potential. Alternative valuation metrics show a price-to-sales ratio of 0.26 and an EV/EBITDA of 7.83, suggesting the company is valued at a fraction of its revenue and at a relatively low multiple of its earnings before interest, taxes, depreciation, and amortization. The stock has traded between a 52-week low of $239.51 and a 52-week high of $350.00, and without the current price explicitly provided in the source data, the valuation context is derived from these historical trading bounds. The beta value is 0.27, which indicates that the stock's price volatility is substantially lower than that of the broader market, suggesting it behaves more like a defensive asset during market fluctuations.
Growth & Income
Revenue growth for the year-over-year period is 10.4%, whereas earnings growth is -9.3%, demonstrating that earnings are currently shrinking faster than revenue, which implies rising cost pressures or margin compression affecting profitability. As a dividend payer, the company offers a dividend yield of 2.3% with a payout ratio of 27.2%, indicating that the dividend is highly sustainable given that it covers less than one-third of the net income. The low payout ratio allows the company to retain a majority of its earnings for reinvestment, balance sheet strengthening, or potential future share repurchases rather than distributing all profits. The overall growth and income profile presents a scenario of solid top-line expansion that is currently outpacing profitability growth, supported by a sustainable dividend yield that offers income to shareholders while maintaining a conservative approach to dividend distribution relative to earnings generation.